Background and Aims: Bone morphogenetic proteins (BMPs) are usually administered with a solid framing material during open surgery. In some instances, percutaneous administration of injectable BMP would be preferable. We tested the new bone-forming activity of injectable native reindeer BMP extract in the Balb/C mouse thigh muscle pouch model.
gene technology (2-4). Native BMP extract comprises a cocktail of purified proteins containing multiple BMPs and other non-BMP proteins (5-8). The stimulating effects of these proteins on bone healing have been well established in many experimental animal and clinical studies (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . BMPs are usually administered with a solid framing material during open surgery (20) (21) (22) (23) , which involves a significant risk of infection and morbidity. In some instances, percutaneous injection of BMP would be preferable. Percutaneous administration of BMP-7 and rhBMP-2 has been successfully used in different experimental animal models (24) (25) (26) (27) , but injection of native BMP extract has received only scant attention (28) .
INTRODUCTION
Bone morphogenetic proteins (BMP), which were originally described by Urist in 1965, constitute a large family of bone-inductive proteins (1). They can be produced by purification from bone tissues of different mammalian species or by the recombinant We investigated the suitability of percutaneous administration of native reindeer BMP extract in the mouse thigh muscle pouch model (7, 8, 29) .
MATERIALS AND METHODS

PREPARATION OF NATIVE REINDEER (RANGIFER TARANDUS) BMP EXTRACT
Native reindeer BMP extract was prepared from reindeer diaphyseal bones. Cortical bones from each animal were chilled immediately after death. The epiphyseal ends, bone marrow and periosteum were mechanically removed, and the cleaned cortical bones were sawn and, after freezing in liquid nitrogen, ground to a particle size of 1.0 mm 3 . The bone matrix was extracted in 4 M GuHCl at 4 o C after demineralization of the pulverized bone in 0.6 M HCl. The GuHCl-extracted solution was filtered with a tangential flow system and concentrated. The concentrated solution was dialyzed against deionized water, and the water-insoluble material was collected. After redissolution into 4 M GuHCl solution, the water-insoluble material was dialyzed against 0.25 M citrate buffer, ph 3.1. The citrate-buffer-insoluble material was washed with deionized water and lyophilized (8, 30).
MATERIALS TO BE TESTED AND STUDY GROUPS
1. Native reindeer BMP extract (from the same batch in the whole experiment) and gelatine (Type A from porcine skin, Bloom 300, Sigma Chemicals Co., St Louis, USA) were mixed with 0.9 % saline to obtain a homogenized emulsion. The total volume of emulsion was 1 ml, which contained 60 mg of BMP and 100 mg of gelatine. Gel/BMP group (5 animals, n = 10).
2. Native reindeer BMP (60 mg) was mixed with 1 ml of 0.9 % saline into a homogenized emulsion. NaCl/BMP group (5 animals, n = 10).
3. As in 1. but without BMP. Gel group (5 animals, n = 10). 4. As in 2. but without BMP. NaCl group (5 animals, n = 10).
INJECTION TECHNIQUES
Male Balb/C mice aged 10-12 weeks were used. One hundred microlitres of the test material was injected (1000 µ l syringe, 20 G needle) in sterile conditions into both thigh muscles under neuroleptic analgesia (Hypnorm Janssen, Belgium; Dormicum, Roche, Switzerland). The dose of native reindeer BMP extract was thus 6 mg/injection in each BMP group. The animals were killed in a chamber with carbon dioxide 21 days after the injections, and the hind legs were harvested (7, 8, 29, 31) . The study protocol was accepted by the Ethical Committee of the University of Oulu.
NEW BONE FORMATION AND ITS DENSITY EVALUATED BY RADIOGRAPHS
After the harvest, standard lateral position radiographs (100 mA, 20 kV, 0,08 s/exp; Mamex de Maq, Soredex, Orion) were taken of the hind legs. The radiographic images were transferred into a computer by using an optical scanner (HP Laser Jet/Desk Scan). New bone formation was evaluated as the area (mm 2 ) of calcified tissue visible in the radiographs by using the Scion Image (Scion Corp., USA) software. The mean optical density (mmAl 3 ) of the defined area was measured with the same equipment. The calibration of the equipment used to measure optical density was performed using an aluminium wedge.
CA 45 ACTIVITY Twenty-four hours before the execution of the animals, all mice received an intraperitoneal injection of diluted carrier-free Ca 45 solution (Amersham, England, 40 µ Ci/kg of body weight). The muscle tissue of each harvested hind leg, including an implant and newly formed bone, was taken en bloc for a specimen immediately after the radiography. A piece of intact foreleg muscle was used as reference (5 samples). All specimens were weighed and digested in a mixture of 0.2 ml of 70 % perchloric acid and 0.4 ml of 33 % peroxide at 70 o C for 3 hours. 0.6 ml of the digested solution was pipetted into a diffuse scintillation vial, and 5 ml of scintillation cocktail (OptiPhase 'Hi-safe 3', Wallac, Finland) was added. The samples were counted in a liquid scintillation counter (Wallac 1410, Pharmacia, Finland) with an internal spectrum library. Ca 45 incorporation into tissue was expressed as DPM/mg of tissue.
STATISTICS
Statistical analysis was performed using the SPSS for Windows statistical package (SPSS Inc., versoin 9.0). The nonparametric Kruskal-Wallis test was used to evaluate the statistical differences between the groups and the Mann-Whitney U-test for pairwise comparisons. Values of p < 0.05 were considered statistically significant.
RESULTS
The injections were easy to perform and well tolerated by the mice. There were no complications during or after the procedure, and no infections were seen.
NEW BONE FORMATION
Control injections without native reindeer BMP extract were not able to induce new bone visible in radiographs. Injections containing native reindeer BMP extract (Gel/BMP and NaCl/BMP groups) resulted in abundant bone formation. (Fig. 1) The mean new bone area and its density were most marked in the NaCl/BMP group. However, there were no significant differences between Gel/BMP and NaCl/BMP with regard to the formation (p = 0.247) and density (p = 0.739) of new bone. (Table 1) CA 45 INCORPORATION Ca 45 incorporation was manifold in the Gel/BMP and NaCl/BMP groups compared to the corresponding control groups without native reindeer BMP extract (Gel, NaCl) (p = 0.000) ( Table 2) . Ca 45 incorporation was most marked in the Gel/BMP group. However, there was no significant difference in Ca 45 incorporation between the Gel/BMP and NaCl/BMP groups (p = 0.739).
DISCUSSION
Injectable BMP implants, applicable with a minimally invasive technique, would be suitable for the treatment of different bone healing problems. Some experimental animal studies with injectable implants have been performed by using native bovine BMP extract and recombinant BMPs (24-28).
Muschik et al (2000) reported dose-dependent bone formation and effective anterior spine fusion in rabbits after the injection of native bovine BMP (28). Forslund et al (1998) showed BMP-7 with acetate buffer to induce a large amount of bone when injected percutaneously into the rat achilles tendon region (26) . Blokhuis et al (2001) studied the injection of BMP-7 with acetate buffer and collagenous matrix in the closed diaphyseal fracture model of goats (25) . They reported the injections to accelerate the healing of closed fractures, and no histological signs of any adverse effects were observed. Li et al (2002) used a rabbit model of leg lengthening and reported the injection of rhBMP-2 with buffer to enhance the consolidation of distraction osteogenesis (27) . Moreover, the studies by Bax et al (1999) showed the injection of rhBMP-2 with buffer to accelerate the healing of rabbit tibial fractures (24) . These studies are in line with our results, which showed a single injection of native reindeer BMP extract to induce effectively new bone formation in a mesenchymal environment in the thigh muscle pouch of mice.
The previous studies, with the exception of that of Muschik et al (2000) , have been performed by using recombinant BMPs (24) (25) (26) (27) (28) . Due to the reservations about using native protein products after the epidemic of bovine spongioform encephalopathy, the majority of clinical research has focused on recombinant BMPs (32) . There are 2 recombinant BMPs (BMP-2 and 7) on the market for clinical use with limited indications (3, 10, 33, 34) . In view of the fact that about 20 BMPs are known, these products consisting of a single BMP cannot be regarded as ideal. Native BMPs consist of a mixture of BMPs, as in living organisms. Therefore, studies aiming at safe and effective products from native BMPs can still be considered justified.
It has been suggested that BMPs need a carrier, which acts as releaser, for effective bone induction, and that the amount of BMP needed could be re-duced by using a carrier (20, 22) . However, Li et al (2002) and Bax et al (1999) reported that BMP injections with buffer healed bone defects more efficiently than the implantation of BMP with collagenous carrier (24, 27) . Blokhuis et al (2001) showed the stimulatory effect of injection of BMP-7 with sodium acetate buffer to be comparable to the effect of injection of BMP-7 with collagenous matrix (25) . Forslund et al (1998) also reported percutaneous injection of BMP-7 without carrier material into the rat achilles tendon region to induce a large amount of bone (26) . Our results, which are in line with the above mentioned studies, showed the injection of native reindeer BMP extract with physiological saline to induce new bone formation equally well or even better than the injection of BMP with collagenous carrier, which confirms the previous findings.
The effective bone formation without collagenous carrier may be partly explained by the amount of injected BMP. Forslund et al (1998) assumed that the quite large amount of OP-1 used in their study might explain the fact that no collagenous carrier was needed (26) . Blokhuis et al (2001) used an even larger dose of OP-1 than Forslund et al (25) , and we also used an excessive amount of native reindeer BMP extract. The previous assumption is partly supported by Muschik et al, who reported that bone formation was not so efficient when a small amount of native bovine BMP was injected (28) . One might postulate that when BMP is administered in large doses, the responding cells at the site of injection are more likely enabled to come into contact with BMP. The slow release of BMP induced by collagen might be more important when smaller doses of collagen are used. At least as estimated based on radiographic new bone formation, our results suggest that carrier materials NaCl/BMP vs NaCl p = 0.000 Gel/BMP vs Gel p = 0.000 of different origins are not always necessary with injectable BMP implants. This might be important for reducing the number of rejections and complications caused by carrier. The experimental model used here has some, though not great, clinical relevance. In clinical situations, the injection must be made into tissues with different consistency, such as bone defects, nonunited fractures, etc. The target of injection should be properly localized beforehand, and the solution should remain evenly in the target area. In this respect, the carrier and its consistency may play an important role. The experimental model used here demonstrated that the native reindeer BMP extract can be applied by injection, and that the injection induces bone formation, i.e. the injected material is distributed locally, which keeps it effective, and not spread widely into the tissue, whereupon it loses its effect.
In conclusion, the injection of native reindeer BMP extract with collagen or physiological saline induced effectively new bone formation in the mouse thigh muscle pouch. Both of these vehicles proved to be suitable carrier materials for injectable native reindeer BMP extract.
